Suppr超能文献

《关于 Phelan-McDermid 综合征管理的更新共识指南》。

Updated consensus guidelines on the management of Phelan-McDermid syndrome.

机构信息

Department of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA.

Rosamund Stone Zander Translational Neuroscience Center, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

Am J Med Genet A. 2023 Aug;191(8):2015-2044. doi: 10.1002/ajmg.a.63312. Epub 2023 Jul 1.

Abstract

Phelan-McDermid syndrome (PMS) is a genetic condition caused by SHANK3 haploinsufficiency and characterized by a wide range of neurodevelopmental and systemic manifestations. The first practice parameters for assessment and monitoring in individuals with PMS were published in 2014; recently, knowledge about PMS has grown significantly based on data from longitudinal phenotyping studies and large-scale genotype-phenotype investigations. The objective of these updated clinical management guidelines was to: (1) reflect the latest in knowledge in PMS and (2) provide guidance for clinicians, researchers, and the general community. A taskforce was established with clinical experts in PMS and representatives from the parent community. Experts joined subgroups based on their areas of specialty, including genetics, neurology, neurodevelopment, gastroenterology, primary care, physiatry, nephrology, endocrinology, cardiology, gynecology, and dentistry. Taskforce members convened regularly between 2021 and 2022 and produced specialty-specific guidelines based on iterative feedback and discussion. Taskforce leaders then established consensus within their respective specialty group and harmonized the guidelines. The knowledge gained over the past decade allows for improved guidelines to assess and monitor individuals with PMS. Since there is limited evidence specific to PMS, intervention mostly follows general guidelines for treating individuals with developmental disorders. Significant evidence has been amassed to guide the management of comorbid neuropsychiatric conditions in PMS, albeit mainly from caregiver report and the experience of clinical experts. These updated consensus guidelines on the management of PMS represent an advance for the field and will improve care in the community. Several areas for future research are also highlighted and will contribute to subsequent updates with more refined and specific recommendations as new knowledge accumulates.

摘要

佩兰-麦克德米德综合征(PMS)是一种由 SHANK3 单倍不足引起的遗传疾病,其特征是广泛的神经发育和系统表现。2014 年首次发表了针对 PMS 个体评估和监测的实践参数;最近,基于纵向表型研究和大规模基因型-表型调查的数据,人们对 PMS 的认识有了显著提高。这些更新的临床管理指南的目的是:(1)反映 PMS 的最新知识;(2)为临床医生、研究人员和普通社区提供指导。成立了一个由 PMS 临床专家和家长社区代表组成的工作组。专家根据其专业领域加入了不同的小组,包括遗传学、神经病学、神经发育学、胃肠病学、初级保健、物理治疗学、肾脏病学、内分泌学、心脏病学、妇科学和牙科学。工作组成员在 2021 年至 2022 年期间定期开会,并根据迭代反馈和讨论制定了专业特定的指南。然后,工作组领导在各自的专业组内达成共识,并协调了指南。过去十年中获得的知识使我们能够改进评估和监测 PMS 个体的指南。由于针对 PMS 的具体证据有限,干预措施主要遵循针对发育障碍个体的一般指南。虽然主要来自照顾者的报告和临床专家的经验,但已经积累了大量的证据来指导 PMS 中合并的神经精神疾病的管理。这些更新的 PMS 管理共识指南代表了该领域的一项进展,将改善社区中的护理。还强调了几个未来研究领域,随着新知识的积累,这些领域将有助于随后的更新,并提出更精细和具体的建议。

相似文献

1
Updated consensus guidelines on the management of Phelan-McDermid syndrome.
Am J Med Genet A. 2023 Aug;191(8):2015-2044. doi: 10.1002/ajmg.a.63312. Epub 2023 Jul 1.
2
Clinical, genetic, and cognitive correlates of seizure occurrences in Phelan-McDermid syndrome.
J Neurodev Disord. 2024 May 10;16(1):25. doi: 10.1186/s11689-024-09541-0.
4
Gait Abnormalities in Children with Phelan-McDermid Syndrome.
J Child Neurol. 2023 Dec;38(13-14):665-671. doi: 10.1177/08830738231204395. Epub 2023 Oct 18.
5
Phenotypic variation in neural sensory processing by deletion size, age, and sex in Phelan-McDermid syndrome.
J Neurodev Disord. 2025 Aug 25;17(1):51. doi: 10.1186/s11689-025-09642-4.
6
Clinical trial of insulin-like growth factor-1 in Phelan-McDermid syndrome.
Mol Autism. 2022 Apr 8;13(1):17. doi: 10.1186/s13229-022-00493-7.
7
[Clinical and genetic analysis of four patients with Phelan-McDermid syndrome due to variants of SHANK gene].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2025 May 10;42(5):563-567. doi: 10.3760/cma.j.cn511374-20250213-00074.
8
Phelan-McDermid syndrome in a Chinese pediatric patient: A case report - new heterozygous mutations lead to PMS.
Medicine (Baltimore). 2025 Sep 5;104(36):e44114. doi: 10.1097/MD.0000000000044114.
9
Psychometric Study of the Social Responsiveness Scale in Phelan-McDermid Syndrome.
Autism Res. 2020 Aug;13(8):1383-1396. doi: 10.1002/aur.2299. Epub 2020 May 14.
10
The Black Book of Psychotropic Dosing and Monitoring.
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.

引用本文的文献

1
Phelan-McDermid syndrome in a Chinese pediatric patient: A case report - new heterozygous mutations lead to PMS.
Medicine (Baltimore). 2025 Sep 5;104(36):e44114. doi: 10.1097/MD.0000000000044114.
4
Psychopharmacology in children with genetic disorders of epigenetic and chromatin regulation.
J Neurodev Disord. 2025 Apr 24;17(1):21. doi: 10.1186/s11689-025-09605-9.
5
Clinical profiling and medical management of Israeli individuals with Phelan McDermid syndrome.
Orphanet J Rare Dis. 2025 Mar 18;20(1):132. doi: 10.1186/s13023-025-03598-3.
6
Diagnosis and treatment of bipolar disorder in Phelan-McDermid syndrome: A case report and review of literature.
World J Psychiatry. 2025 Feb 19;15(2):101948. doi: 10.5498/wjp.v15.i2.101948.
8
A roadmap for SHANK3-related Epilepsy Research: recommendations from the 2023 strategic planning workshop.
Ther Adv Rare Dis. 2024 Sep 5;5:26330040241273464. doi: 10.1177/26330040241273464. eCollection 2024 Jan-Dec.
9
Aortic Root Dilation and Genotype Associations in Phelan-McDermid Syndrome.
Am J Med Genet A. 2025 Jan;197(1):e63872. doi: 10.1002/ajmg.a.63872. Epub 2024 Sep 11.
10
Adult syndromology: challenges, opportunities and perspectives: .
Med Genet. 2024 Jun 6;36(2):95-102. doi: 10.1515/medgen-2024-2023. eCollection 2024 Jun.

本文引用的文献

1
Sleep and Phelan-McDermid Syndrome: Lessons from the International Registry and the scientific literature.
Mol Genet Genomic Med. 2022 Oct;10(10):e2035. doi: 10.1002/mgg3.2035. Epub 2022 Aug 23.
2
Rare coding variation provides insight into the genetic architecture and phenotypic context of autism.
Nat Genet. 2022 Sep;54(9):1320-1331. doi: 10.1038/s41588-022-01104-0. Epub 2022 Aug 18.
3
Sensory processing and adaptive behavior in Phelan-McDermid syndrome: a cross-sectional study.
Eur J Pediatr. 2022 Aug;181(8):3141-3152. doi: 10.1007/s00431-022-04564-y. Epub 2022 Jul 15.
4
Variability in Phelan-McDermid Syndrome in a Cohort of 210 Individuals.
Front Genet. 2022 Apr 12;13:652454. doi: 10.3389/fgene.2022.652454. eCollection 2022.
5
Clinical trial of insulin-like growth factor-1 in Phelan-McDermid syndrome.
Mol Autism. 2022 Apr 8;13(1):17. doi: 10.1186/s13229-022-00493-7.
6
Phelan-McDermid syndrome: a classification system after 30 years of experience.
Orphanet J Rare Dis. 2022 Jan 29;17(1):27. doi: 10.1186/s13023-022-02180-5.
7
Parent-reported measure of repetitive behavior in Phelan-McDermid syndrome.
J Neurodev Disord. 2021 Nov 5;13(1):53. doi: 10.1186/s11689-021-09398-7.
8
A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome.
Mol Autism. 2021 Sep 30;12(1):62. doi: 10.1186/s13229-021-00459-1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验